Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease.

Autor:	van der Woude, C. Janneke, Stokkers, Pieter, van Bodegraven, Ad A., Van Assche, Gert, Hebzda, Zbigniew, Paradowski, Leszek, D'Haens, Geert, Ghosh, Subrata, Feagan, Brian, Rutgeerts, Paul, Dijkstra, Gerard, de Jong, Dirk J., Oldenburg, Bas, Farhan, Mahdi, Richard, Tristan, Dean, Yann, Hommes, Daniel W.
Zdroj:	Inflammatory Bowel Diseases; Oct2010, Vol. 16 Issue 10, p1708-1716, 9p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text